Share on LinkedInShare on LinkedIn

ARTICLE · 01 AUGUST 2023

Revised Interim Director Review Process In AIA Proceedings

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

To be sure, under prior guidance, the Director would occasionally review, sua sponte, Board institution decisions.

United StatesIntellectual Property

On July 24, 2023, the United States Patent and Trademark Office (USPTO or Office) revised its interim process for the review of decisions of the Patent Trial and Appeal Board (PTAB or Board) by the Director of the USPTO in America Invents Act (AIA) proceedings.

Following the Supreme Court's decision in United States v. Arthrex, Inc., on June 29, 2021, the Office set forth an interim process for the Director to review final Board decisions. 141 S. Ct. 1970, 1986 (2021). After further updating that guidance on May 25, 2022, and June 17, 2022, the Office issued a Request for Comments on July 20, 2022, seeking public feedback on the interim Director Review process. The Office received 4,377 comments.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from